HCV Screening to Enable Early Treatment of Hepatitis C: A athematical Model to Analyse Costs and Outcomes in Two Populations

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|17|1655-1660

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.17, 2008-06, pp. : 1655-1660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fragment-Based Development of HCV Protease Inhibitors for the Treatment of Hepatitis C

By  

Current Computer - Aided Drug Design, Vol. 8, Iss. 1, 2012-03 ,pp. : 55-61

Bentham Science Publishers

Access to resources Recommend Favorite

The monoclonal antibody XTL 002 [HCV-AB68] has potential in the treatment of chronic hepatitis C virus (HCV) infection

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines

By Siebert Uwe   Sroczynski Gaby   Aidelsburger Pamela  

PharmacoEconomics, Vol. 27, Iss. 4, 2009-06 ,pp. : 341-354

Adis International

Access to resources Recommend Favorite

Ligand and Structure Based Virtual Screening Strategies for Hit-Finding and Optimization of Hepatitis C Virus (HCV) Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 17, 2011-06 ,pp. : 2612-2619

Bentham Science Publishers

Access to resources Recommend Favorite

HCV Treatment Decision-Making Substance Use Experiences and Hepatitis C Treatment Decision-Making Among HIV/HCV Coinfected Adults

By Ogawa Lisa M. Fink   Bova Carol  

Substance Use & Misuse, Vol. 44, Iss. 7, 2009-06 ,pp. : 915-933

Informa Healthcare

Access to resources Recommend Favorite